English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/87094
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Non-ATP competitive glycogen synthase kinase 3β (GSK-3β) inhibitors: Study of structural requirements for thiadiazolidinone derivatives

AuthorsCastro, Ana ; Encinas, Arantxa; Gil, Carmen ; Bräse, Stefan; Porcal, Williams; Pérez, Concepción; Moreno, J.; Martínez, Ana
Issue Date2008
PublisherPergamon Press
CitationBioorganic and Medicinal Chemistry 16: 495- 510 (2008)
AbstractThe 2,4-disubstituted thiadiazolidinones (TDZD) were described as the first non-ATP competitive GSK-3β inhibitors. New modifications in this heterocyclic ring are here reported to study the influence on the biological activity. The basic skeleton of 1,2,4-thiadiazole and also one of the carbonyl groups are kept, while different modifications are introduced in positions 3 and 5, respectively. The GSK-3β activity of the new thiadiazole derivatives here synthesized showed IC50 values for some of the compounds in the micromolar range. Additionally, ATP competition studies have been carried out, showing that as well as the first generation of TDZD, these new compounds act in a non-competitive manner. With this study, additional requirements for the biological activity of the TDZD family have been delineated. © 2007 Elsevier Ltd. All rights reserved.
URIhttp://hdl.handle.net/10261/87094
DOI10.1016/j.bmc.2007.09.016
Identifiersdoi: 10.1016/j.bmc.2007.09.016
issn: 0968-0896
e-issn: 1464-3391
Appears in Collections:(CBM) Artículos
(IQM) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.